Effective treatment strategies for inflammatory bowel disease

Research output: Contribution to journalArticle

Abstract

The treatment of inflammatory bowel disease (IBD) has changed significantly since the introduction of immune system altering biologics. Using these agents in combination with older agents can induce a sustained remission that will likely reduce the progression of the disease and the need for surgeries. Evidence-based guidelines should be used to steer therapy to achieve and maintain sustained remissions.

Original languageEnglish (US)
Pages (from-to)16-21
Number of pages6
JournalJournal of Managed Care Medicine
Volume16
Issue number3
StatePublished - Sep 16 2013
Externally publishedYes

Fingerprint

Biological Products
Inflammatory Bowel Diseases
Disease Progression
Immune System
Guidelines
Therapeutics

All Science Journal Classification (ASJC) codes

  • Health Policy

Cite this

@article{8eefcac1ea87438fb7935871740cc528,
title = "Effective treatment strategies for inflammatory bowel disease",
abstract = "The treatment of inflammatory bowel disease (IBD) has changed significantly since the introduction of immune system altering biologics. Using these agents in combination with older agents can induce a sustained remission that will likely reduce the progression of the disease and the need for surgeries. Evidence-based guidelines should be used to steer therapy to achieve and maintain sustained remissions.",
author = "Joel Rosh",
year = "2013",
month = "9",
day = "16",
language = "English (US)",
volume = "16",
pages = "16--21",
journal = "Journal of Managed Care Medicine",
issn = "1094-1525",
publisher = "National Association of Managed Care Physicians",
number = "3",

}

Effective treatment strategies for inflammatory bowel disease. / Rosh, Joel.

In: Journal of Managed Care Medicine, Vol. 16, No. 3, 16.09.2013, p. 16-21.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effective treatment strategies for inflammatory bowel disease

AU - Rosh, Joel

PY - 2013/9/16

Y1 - 2013/9/16

N2 - The treatment of inflammatory bowel disease (IBD) has changed significantly since the introduction of immune system altering biologics. Using these agents in combination with older agents can induce a sustained remission that will likely reduce the progression of the disease and the need for surgeries. Evidence-based guidelines should be used to steer therapy to achieve and maintain sustained remissions.

AB - The treatment of inflammatory bowel disease (IBD) has changed significantly since the introduction of immune system altering biologics. Using these agents in combination with older agents can induce a sustained remission that will likely reduce the progression of the disease and the need for surgeries. Evidence-based guidelines should be used to steer therapy to achieve and maintain sustained remissions.

UR - http://www.scopus.com/inward/record.url?scp=84883695673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883695673&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 16

EP - 21

JO - Journal of Managed Care Medicine

JF - Journal of Managed Care Medicine

SN - 1094-1525

IS - 3

ER -